← Latest briefing

Health

JAMA paper argues autonomous AI will soon provide better medical care than human doctors

The coauthors predict autonomous AI will surpass both human clinicians and human-AI hybrids in five fundamental medical tasks by 2030.

The short version

  • A paper published in the Journal of the American Medical Association (JAMA) predicts that autonomous AI will surpass human physicians and human-AI hybrids in delivering medical care by 2030.
  • The authors argue that AI will excel at five core tasks: taking medical histories, establishing diagnoses, identifying needed tests, prescribing treatments, and managing chronic diseases.
  • While some experts agree that AI's capabilities are rapidly advancing, critics defend the necessity of human governance in care plans and emphasize irreplaceable human qualities like empathy.

Key facts

  • A JAMA article coauthored by Ezekiel Emanuel, Vinod Khosla, Neal Khosla, and others argues that autonomous AI will exceed human physicians and physician-AI hybrids in delivering medical care.[Wired]
  • The paper identifies five fundamental medical tasks where AI is expected to outperform humans: taking medical histories, establishing diagnoses, identifying needed tests, prescribing treatments, and managing chronic diseases.[Wired]
  • The coauthors analyzed published research on medical AI from January 1, 2024, to the present to support their prediction of an autonomous AI transition by 2030.[Wired]
  • American Medical Association CEO John Whyte criticized the paper's methodology, noting that some of the surveyed studies are simulations rather than blind experiments.[Wired]
  • Robert Wachter, head of medicine at UCSF, acknowledged that AI may eventually outperform humans in certain tasks but argued that clinicians remain irreplaceable for uniquely human functions like delivering grim prognoses.[Wired]
  • Conflicts of interest disclosed in the paper include coauthor Neal Khosla's role running Curai Health, an online company using AI to treat patients, as well as Vinod Khosla's investments and Emanuel's consultancies.[Wired]

What remains uncertain

  • It is uncertain if or when autonomous AI systems will receive regulatory permission to independently prescribe medicine.[Wired]
  • Whether medical training and residency programs can effectively adapt to prevent the 'de-skilling' of future doctors who rely heavily on AI assistance remains an ongoing debate.[Wired]

Sources